Crinetics Pharmaceuticals (CRNX) Operating Margin Growth (3y) (2020 - 2026)

Crinetics Pharmaceuticals (CRNX) Operating Margin Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Oculis Holding AG 67,462.92 Bn 67,462.64 Bn - -
2 Nanobiotix 1,941.00 Bn 1,940.94 Bn - -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn - -
4 BeOne Medicines 473.07 Bn 468.27 Bn 1.35 Bn 9,942.00
5 Vertex Pharmaceuticals 123.28 Bn 116.03 Bn 2.59 Bn 530.00
6 Regeneron Pharmaceuticals 70.12 Bn 61.37 Bn 3.31 Bn -1,211.00
7 Belite Bio 62.40 Bn 62.40 Bn - -
8 Argenx Se 56.45 Bn 51.27 Bn 1.41 Bn -623.00
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn 6,993.00
10 Crinetics Pharmaceuticals 8.72 Bn 7.43 Bn 10.53 Mn 48,310.00

Historic Data

Download Data
DateValue
Mar 31, 2026 48,310.00
Dec 31, 2025 453,792.00
Sep 30, 2025 -9.02 Mn
Jun 30, 2025 -271,775.00
Mar 31, 2025 -2.98 Mn
Mar 31, 2023 2.33 Mn
Dec 31, 2022 -196,791.00
Sep 30, 2022 -647,213.00
Mar 31, 2022 165,640.00
Dec 31, 2021 -165,775.00
Dec 31, 2020 3.12 Mn